Welcure Drugs & Pharmaceuticals shareholders and shareholding pattern
BSE: 524661Pharmaceuticals & BiotechnologySmall Cap
Welcure Drugs & Pharmaceuticals ltd · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1994
Last close ₹0.18₹0.00 (0.00%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹0.18.
30 Oct: open ₹0.18, high ₹0.19, low ₹0.17
52-week range of traded prices to 30 Oct 2026
₹0.17Low, 23 Oct 2026₹0.64High, 13 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹22 Cr3,646th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 86,46,796
Welcure Drugs & Pharmaceuticals' shareholding pattern for Mar 2026, filed on 21 Apr 2026, with every filing from Jun 2016: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Welcure Drugs & Pharmaceuticals, filing by filing
Per cent of the company's shares.
Mar 2026 filing
- PromotersNone
- Indian institutionsNone
- Individuals and others100.00%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Indian institutions
- Individuals and others
| Per cent | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | None | None | None | None | None | None | None | None | None | None | None | None | None | None | None | |
| Indian promoters | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | 14.12% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 85.88% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Shares in issue | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 1,35,12,100 | 11,25,12,100 | 11,25,12,100 | 11,23,58,200 | 11,23,58,200 | 1,23,59,40,200what Shares in issue, Dec 2025, includes. Bonus issue on 16 Oct 2025: 1 new share for every 10 held. Split on 16 Oct 2025: each share became 10. Earlier filings count the shares before them. | 1,23,59,40,200 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9,90,00,000 | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “None” is a filing that names no promoter holding shares. “Under 0.01%” is a holding of shares too small to show at two decimals.
Largest public holders of Welcure Drugs & Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KIFS TRADE CAPITAL PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.00% | 1.00% | – |
| TECHROXY SOLUTION PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.78% | – | – |
| MODUPALLI RAMESHResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.25% | – | – |
| NISHANT GOYALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.23% | – | – |
| L7 HITECH PRIVATE LIMITEDCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.02% | – | – |
| MANISH RAJPUTResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.78% | 9.78% | 9.79% | – | – | – |
| RAHUL RATANSINGH SIKARWARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 9.78% | 9.78% | 9.79% | – | – | – |
| AVINASHBHAI GOVINDBHAI PARMARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.89% | 8.89% | 8.90% | – | – | – |
| AKSHAY NADIYAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.89% | 8.89% | 8.90% | – | – | – |
| KULDEEP RANVIRSINGH TOMARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.89% | 8.89% | 8.90% | – | – | – |
| TATAD NAYAN GAUTAMBHAIResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.89% | 8.89% | 8.90% | – | – | – |
| GOVINDSINGH BHAVNATHSINGH RAJBHARResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.00% | 8.00% | 8.01% | – | – | – |
| JAYDEEP BHOSLEResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.00% | 8.00% | 8.01% | – | – | – |
| MITESH MAKVANAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.00% | 8.00% | 8.01% | – | – | – |
| ANKUSH RAJKUMAR DABHANEResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 8.89% | 8.89% | 5.53% | – | – | – |
| RUCHIRA GOYALResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 7.49% | – | – | – | – | – | – |
| MANOJ KUMAR KANDAResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.55% | – | – | – | – | – | – |
| VIZWISE COMMERCE PRIVATE LIMITEDCompanies | – | 4.46% | 4.46% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | – | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | 2.24% | – | – | – | – | – | – |
| SHUBHAM GARGResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.45% | 1.49% | 1.49% | 1.81% | 1.89% | 1.91% | 1.93% | 1.93% | – | – | – | – | – | – |
| SUNIL GOELResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.58% | 1.58% | – | – | – | – | – | – |
| VINOD K SResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.47% | 1.47% | 1.47% | 1.49% | 1.50% | 1.50% | – | – | – | – | – | – | – | – |
| Madhudevi Sanjay BuchaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 11.84% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Shri Parasram Hldgs LtdOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.70% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Globe Capital Market LtdOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.61% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Deepa Navin PamnaniResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.48% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SANDEEP JAINResident individuals, over ₹2 lakh at face value | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | 15.07% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| LATA JAINResident individuals, over ₹2 lakh at face value | 7.18% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.18% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | 7.85% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| SANJEEV JAINResident individuals, over ₹2 lakh at face value | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | 7.11% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| WELCURE PHARMACEUTICALS PRIVATE LIMITEDOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.87% | – | – | – | – | – | – | – | 2.87% | 2.87% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| DINESH KUMAR JAINResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.10% | 1.11% | 1.21% | 1.28% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| BITS LIMITEDOther non-institutions | – | 1.45% | 1.45% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 3.67% | 2.31% | 1.63% | 1.63% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Welcure Pharmaceuticals (P) LtdOther non-institutions | – | 2.00% | 2.00% | 2.00% | 2.00% | 2.00% | 2.87% | 2.87% | 2.87% | 2.87% | 2.87% | 2.87% | 2.87% | 2.87% | 2.87% | – | 2.00% | 2.87% | 2.87% | 2.87% | 2.87% | 2.87% | 0.87% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| VIZWISE COMMERCIAL PRIVATE LIMITEDOther non-institutions | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.24% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Mar 2026 filing
Against the Dec 2025 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Individuals and others: KIFS TRADE CAPITAL PRIVATE LIMITED no longer named, from 1.00%